International Journal of Epidemiology 2000;29:941-947
© International Epidemiological Association 2000
High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study
a Centro de Triagem Neonatal and Laboratório Nobel RIE. Av. Ipiranga, 5.000, Porto Alegre, RS, 90.610–000, Brazil. E-mail: nobelrie{at}voyager.com.br or eneto{at}voyager.com.br
b Labsystems Research Laboratories, Sorvaajankatu 15, 00811, Helsinki, Finland.
Background A pilot neonatal screening programme revealed a high (approximately 1 per 4800 live births) prevalence of congenital toxoplasmosis (CT) in the State of Rio Grande do Sul, Brazil. The purpose of this paper was to estimate in a larger prospective study the prevalence of CT in the country.
Methods At the beginning of the study, an in-house indirect enzyme immunoassay (EIA) was used, to be later replaced with a commercial capture IgM fluorometric enzyme immunoassay (FEIA). Both methods detect specific anti-Toxoplasma gondii IgM-class antibodies eluted from dried blood spots.
Results Of the total of 140 914 samples received from all over the country, 47 cases were identified and confirmed as CT. This finding suggests a prevalence of 1 per 3000 live births. Of the 47 patients, only eight (17%) had clinical manifestations: two had intracranial calcifications, four had retinal scars, one had an intracranial calcification and retinal scars, and one had hepatosplenomegaly with lymphoadenopathy. The testing was paid for by the patients' families who volunteered for the study and gave their informed consent.
Conclusion The 3-year prospective study using sensitive detection methods, reliable confirmation, and feedback from clinicians showed that CT has an extraordinarily high prevalence in Brazil, in fact the highest ever reported in the world. Although the long-term efficacy of treatment of CT has not been well documented, in view of the availability of reliable diagnostics, confirmation and monitoring, functional logistics, and networking for screening, the insidious nature of the sequelae and the very high prevalence of the disease, neonatal screening for CT should be considered an alternative to no screening at all.
Keywords Congenital toxoplasmosis, neonatal screening, Brazil, prevalence
Accepted 17 April 2000
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-K. Tan, E. Petersen, L. N. Moller, P. Phillips, E. C. Neto, and R. E. Gilbert Recovery of Anti-Toxoplasma gondii Immunoglobulin M in Stored Guthrie Card Blood Spots J. Clin. Microbiol., August 1, 2009; 47(8): 2626 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rosso, J. T. Les, A. Agudelo, C. Villalobos, J. A. Chaves, G. A. Tunubala, A. Messa, J. S. Remington, and J. G. Montoya Prevalence of Infection with Toxoplasma gondii among Pregnant Women in Cali, Colombia, South America Am J Trop Med Hyg, March 1, 2008; 78(3): 504 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Gilbert and C Dezateux Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established. Arch. Dis. Child., August 1, 2006; 91(8): 629 - 631. [Full Text] [PDF]
|
|
|
|
|
|
R Gilbert, H K Tan, S Cliffe, E Guy, and M Stanford Symptomatic toxoplasma infection due to congenital and postnatally acquired infection Arch. Dis. Child., June 1, 2006; 91(6): 495 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gallego-Marin, A. C. Henao, and J. E. Gomez-Marin Clinical Validation of a Western Blot Assay for Congenital Toxoplasmosis and Newborn Screening in a Hospital in Armenia (Quindio) Colombia J Trop Pediatr, April 1, 2006; 52(2): 107 - 112. [Abstract] [Full Text] [PDF]
|
|